Contact
Please use this form to send email to PR contact of this press release:
LIGAND PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Ligand Pharmaceuticals Investors to Accounting Restatements, Securities Class Action, and Lead Plaintiff Deadline
TO: